Drug interactions

In the last five years there has been increasing awareness of the importance of interactions between drugs in everyday medicine.1 Before that the only interactions commonly considered were those that held some promise of benefiting the patient, such as the use of combinations of drugs that have useful synergic actions, or the use of antidotes for poisoning.

• Publication year

  1967

• Venue

  Drug Calculations for Nurses

• Publication date

  1967-11-10

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/s0140-6736(75)91696-7
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacokinetics of the CYP3A4 and CYP2B6 Inducer Carbamazepine and Its Drug–Drug Interaction Potential: A Physiologically Based Pharmacokinetic Modeling Approach

  2021cited by this paper
• Update on drug-drug interaction at organic cation transporters: mechanisms, clinical impact, and proposal for advanced in vitro testing

  2021cited by this paper
• Clinically Significant Drug-Drug Interaction Between Methadone and Cannabidiol

  2020cited by this paper
• Serotonin syndrome in the perioperative period.

  2020cited by this paper
• Potential Pharmacokinetic Drug-Drug Interactions between Cannabinoids and Drugs Used for Chronic Pain

  2020cited by this paper
• Regulatory Efforts to Facilitate Evaluation and Clinical Management of Drug‐Drug Interaction Risks

  2020cited by this paper
• Predicting the Potential for Cannabinoids to Precipitate Pharmacokinetic Drug Interactions via Reversible Inhibition or Inactivation of Major Cytochromes P450

  2020cited by this paper
• The synthetic cannabinoids phenomenon: from structure to toxicological properties. A review

  2020cited by this paper
• Paradoxical Patterns of Sinusoidal Obstruction Syndrome-Like Liver Injury in Aged Female CD-1 Mice Triggered by Cannabidiol-Rich Cannabis Extract and Acetaminophen Co-Administration

  2019cited by this paper
• Buprenorphine Treatment for Opioid Use Disorder: An Overview

  2019cited by this paper
• Evidence of a clinically significant drug‐drug interaction between cannabidiol and tacrolimus

  2019cited by this paper
• Clinical Studies on Drug–Drug Interactions Involving Metabolism and Transport: Methodology, Pitfalls, and Interpretation

  2019cited by this paper
• A marijuana-drug interaction primer: Precipitants, pharmacology, and pharmacokinetics.

  2019cited by this paper
• Synthetic cannabinoids are substrates and inhibitors of multiple drug-metabolizing enzymes

  2018cited by this paper
• Interaction between CYP2D6 inhibitor antidepressants and codeine: is this relevant?

  2018cited by this paper
• Cross-talk of cannabinoid and endocannabinoid metabolism is mediated via human cardiac CYP2J2.

  2018cited by this paper
• Management of Phenobarbital and Apixaban Interaction in Recurrent Cardioembolic Stroke

  2018cited by this paper
• Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly

  2018cited by this paper
• Chemistry and Structure-Activity Relationships of Psychedelics.

  2018cited by this paper
• Understanding the tumor immune microenvironment (TIME) for effective therapy

  2018cited by this paper
• The pharmacokinetics and the pharmacodynamics of cannabinoids.

  2018cited by this paper
• The Role of CYP2E1 in the Drug Metabolism or Bioactivation in the Brain

  2017cited by this paper
• Pharmacokinetic and pharmacodynamic interactions in anaesthesia. A review of current knowledge and how it can be used to optimize anaesthetic drug administration.

  2017cited by this paper
• An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies

  2017cited by this paper
• Drug‐Induced Serotonin Syndrome

  2017cited by this paper
• Hepatic transporter drug-drug interactions: an evaluation of approaches and methodologies

  2017cited by this paper
• Individual variability in clinical effect and tolerability of opioid analgesics – Importance of drug interactions and pharmacogenetics

  2017cited by this paper
• In vitro to in vivo extrapolation of the complex drug‐drug interaction of bupropion and its metabolites with CYP2D6; simultaneous reversible inhibition and CYP2D6 downregulation

  2017cited by this paper
• Intranasal naloxone and related strategies for opioid overdose intervention by nonmedical personnel: a review

  2017cited by this paper
• DRUG-DRUG INTERACTION PROFILES OF MEDICATION REGIMENS EXTRACTED FROM A DE-IDENTIFIED ELECTRONIC MEDICAL RECORDS SYSTEM

  2016cited by this paper
• Cannabinoids and Cytochrome P450 Interactions.

  2016cited by this paper
• Effects of terbinafine and itraconazole on the pharmacokinetics of orally administered tramadol

  2015cited by this paper
• PharmGKB summary: pathways of acetaminophen metabolism at the therapeutic versus toxic doses

  2015cited by this paper
• Characterization of CYP2B6 in a CYP2B6-Humanized Mouse Model: Inducibility in the Liver by Phenobarbital and Dexamethasone and Role in Nicotine Metabolism In Vivo

  2015cited by this paper
• Pharmacokinetic and Pharmacodynamic Drug Interactions with Ethanol (Alcohol)

  2014cited by this paper
• Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review

  2014cited by this paper
• P-glycoprotein Modulates Morphine Uptake into the CNS: A Role for the Non-steroidal Anti-inflammatory Drug Diclofenac

  2014cited by this paper
• PharmGKB summary: venlafaxine pathway

  2014cited by this paper
• Serotonin syndrome: fentanyl and selective serotonin reuptake inhibitor interactions.

  2014cited by this paper
• Pharmacokinetic drug-drug interaction and their implication in clinical management

  2013cited by this paper
• Risks, Management, and Monitoring of Combination Opioid, Benzodiazepines, and/or Alcohol Use

  2013cited by this paper
• Involvement of UDP-Glucuronosyltransferases UGT1A9 and UGT2B7 in Ethanol Glucuronidation, and Interactions with Common Drugs of Abuse

  2013cited by this paper
• Clinical management of drug-drug interactions in HCV therapy: challenges and solutions.

  2013cited by this paper
• Cytochrome P450-Mediated Changes in Oxycodone Pharmacokinetics/Pharmacodynamics and Their Clinical Implications

  2013cited by this paper
• Valproic acid pathway: pharmacokinetics and pharmacodynamics

  2013cited by this paper
• MDMA, serotonergic neurotoxicity, and the diverse functional deficits of recreational 'Ecstasy' users.

  2013cited by this paper
• The UDP-glucuronosyltransferases: their role in drug metabolism and detoxification.

  2013cited by this paper
• Interactions Between Alcohol and the Antiretroviral Medications Ritonavir or Efavirenz

  2013cited by this paper
• Differential Drug–Drug Interactions of the Synthetic Cannabinoids JWH-018 and JWH-073: Implications for Drug Abuse Liability and Pain Therapy

  2013cited by this paper
• Avoiding Serotonin Syndrome: The Nature of the Interaction Between Tramadol and Selective Serotonin Reuptake Inhibitors

  2012cited by this paper
• Inhibition of CYP2D6-mediated tramadol O-demethylation in methadone but not buprenorphine maintenance patients.

  2012cited by this paper
• The Metabolism of Opioid Agents and the Clinical Impact of Their Active Metabolites

  2011cited by this paper
• Drug interactions associated with methadone, buprenorphine, cocaine, and HIV medications: implications for pregnant women.

  2011cited by this paper
• Duloxetine

  2011cited by this paper
• Can the Chronic Administration of the Combination of Buprenorphine and Naloxone Block Dopaminergic Activity Causing Anti-reward and Relapse Potential?

  2011cited by this paper
• Mechanisms of drug interactions: pharmacodynamics and pharmacokinetics

  2011cited by this paper
• Opioid transport by ATP-binding cassette transporters at the blood-brain barrier: implications for neuropsychopharmacology.

  2011cited by this paper
• Potent inhibition of human cytochrome P450 3A isoforms by cannabidiol: role of phenolic hydroxyl groups in the resorcinol moiety.

  2011cited by this paper
• Subjective, psychomotor, and physiological effects of oxycodone alone and in combination with ethanol in healthy volunteers

  2011cited by this paper
• Simultaneous assessment of cytochrome P450 activity in cultured human hepatocytes for compound-mediated induction of CYP3A4, CYP2B6, and CYP1A2.

  2011cited by this paper
• An analysis of the root causes for opioid-related overdose deaths in the United States.

  2011cited by this paper
• Combined effects of acute, very-low-dose ethanol and delta(9)-tetrahydrocannabinol in healthy human volunteers.

  2011cited by this paper
• Mitochondrial CYP2E1 is sufficient to mediate oxidative stress and cytotoxicity induced by ethanol and acetaminophen.

  2011cited by this paper
• Characterization of major phytocannabinoids, cannabidiol and cannabinol, as isoform-selective and potent inhibitors of human CYP1 enzymes.

  2010cited by this paper
• Deaths involving serotonergic drugs.

  2010cited by this paper
• Effect of cocaine use on buprenorphine pharmacokinetics in humans.

  2010cited by this paper
• The Additive Effects of Alcohol and Benzodiazepines on Driving

  2010cited by this paper
• Drug-Drug Interaction Profiles of Proton Pump Inhibitors

  2010cited by this paper
• Tolerance and cross-tolerance to neurocognitive effects of THC and alcohol in heavy cannabis users

  2010cited by this paper
• Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development.

  2009cited by this paper
• O-demethylation of codeine to morphine inhibited by low-dose levomepromazine

  2009cited by this paper
• Opioid metabolism.

  2009cited by this paper
• Characterization of Human Hepatic and Extrahepatic UDP-Glucuronosyltransferase Enzymes Involved in the Metabolism of Classic Cannabinoids

  2009cited by this paper
• Tramadol: seizures, serotonin syndrome, and coadministered antidepressants.

  2009cited by this paper
• Depressive effect of an antidepressant: therapeutic failure of venlafaxine in a case lacking CYP2D6 activity

  2009cited by this paper
• Mini-series: II. Clinical aspects. Clinically relevant CYP450-mediated drug interactions in the ICU

  2009cited by this paper
• The effect of cannabis compared with alcohol on driving.

  2009cited by this paper
• Cannabinoid Receptors: Where They are and What They do

  2008cited by this paper
• Drugs behave as substrates, inhibitors and inducers of human cytochrome P450 3A4.

  2008cited by this paper
• Impact of Multiple Inhibitors or Substrates of Cytochrome P450 2D6 on Plasma Risperidone Levels in Patients on Polypharmacy

  2008cited by this paper
• Serotonin syndrome triggered by a single dose of suboxone.

  2008cited by this paper
• Enzyme inhibition and induction

  2008cited by this paper
• Pharmacodynamics of diazepam co-administered with methadone or buprenorphine under high dose conditions in opioid dependent patients.

  2007cited by this paper
• Naloxone treatment in opioid addiction: the risks and benefits

  2007cited by this paper
• Concurrent buprenorphine and benzodiazepines use and self-reported opioid toxicity in opioid substitution treatment.

  2007cited by this paper
• Buprenorphine--a review of its role in neuropathic pain.

  2007cited by this paper
• CYP2D6 polymorphism and clinical effect of the antidepressant venlafaxine

  2006cited by this paper
• Interactions on Mixing Diazepam With Methadone or Buprenorphine in Maintenance Patients

  2006cited by this paper
• Induction of P-glycoprotein in lymphocytes by carbamazepine and rifampicin: the role of nuclear hormone response elements.

  2006cited by this paper
• The acute effects of gabapentin in combination with alcohol in heavy drinkers.

  2006cited by this paper
• Evaluation of 227 Drugs for In Vitro Inhibition of Cytochrome P450 2B6

  2006cited by this paper
• Buprenorphine

  2005cited by this paper
• Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity.

  2005cited by this paper
• CYP2C-catalyzed delta9-tetrahydrocannabinol metabolism: kinetics, pharmacogenetics and interaction with phenytoin.

  2005cited by this paper
• Effects of amitriptyline and zimelidine in combination with ethanol

  2004cited by this paper
• Drugs and receptors

  2004cited by this paper
• Commonly used herbal medicines in the United States: a review.

  2004cited by this paper
• Inhibitory effects of memantine on human cytochrome P450 activities: prediction of in vivo drug interactions

  2004cited by this paper
• Brain penetration of methadone (R)- and (S)-enantiomers is greatly increased by P-glycoprotein deficiency in the blood–brain barrier of Abcb1a gene knockout mice

  2004cited by this paper
• Effect of P‐glycoprotein inhibition on methadone analgesia and brain distribution in the rat

  2004cited by this paper

• Contribution and expression of renal drug transporters in renal cell carcinoma

  2025cites this paper
• Role Of Clinical Pharmacist In Identifying And Managing Drug-Drug Interactions In Critical Care Unit- An Interventional Study

  2025cites this paper
• Statistical Forecasting Of Drug-Drug Interactions Using Medicines' Physiological Similarity

  2025cites this paper
• Idealized Framework for Assisting Pharmacovigilance Reporting in an Ambulatory Primary Care and Chronic Disease Management Clinic

  2025cites this paper
• In-depth molecular assessment of Hedera helix's L. α - Hederin & Hederacoside C as a gastroprotective & a possible safe Omeprazole phyto-alternative in ethanol-induced gastric ulcer mice model.

  2025cites this paper
• Prevalence of Iron Deficiency Anaemia in Elderly Aged > 60 Taking Daily Low-Dose Aspirin

  2025cites this paper
• Inconsistent Reporting of Interactions Between Warfarin and Medicinal Plants Across Clinical Decision Support Resources

  2025cites this paper
• Exploring drug interactions between newer antidepressants and medications used to treat neurological disorders

  2025influential citation
• PS3N: leveraging protein sequence-structure similarity for novel drug-drug interaction discovery

  2025cites this paper
• Egyptian pediatric guidelines for the management of childhood venous thromboembolism: the adapted methodology: a limited resource country perspective

  2025cites this paper
• Analysis of drug-drug interactions in spontaneous adverse drug reaction reports from EudraVigilance focusing on psychiatric drugs and somatic medication

  2025cites this paper
• Drug-drug interactions in metastatic hormone-sensitive prostate cancer (mHSPC): practical considerations for treating men with androgen receptor pathway inhibitors and common medications in this stage

  2025influential citation
• From Discovery to Translation: Endogenous Substrates of OAT1 and OAT3 as Clinical Biomarkers for Renal Secretory Function

  2025cites this paper
• Lurcher Mouse as a Model of Cerebellar Syndromes

  2025cites this paper
• Prevalence and factors associated with potential drug-drug interactions in prescriptions presented at private pharmacies in Mbarara city, southwestern Uganda

  2024influential citation
• Coadministration of Cariprazine with a Moderate CYP3A4 Inhibitor in Patients with Schizophrenia: Implications for Dose Adjustment and Safety Monitoring

  2024cites this paper
• Prevalence and solving strategies of drug-related problems in adult psychiatric inpatients - a systematic review

  2024cites this paper
• The High Prevalence and Complexity of Over-the-Counter Medication Misuse in Older Adults

  2024cites this paper
• Possible drug-drug interactions among elderly patients receiving antiviral therapy for chronic hepatitis B

  2024cites this paper
• Role of Pharmacy Professionals in Preventing and Managing High-Alert Medications Errors in Hospitals

  2024cites this paper
• The prevalence of antiretroviral drug interactions with other drugs used in women living with HIV and its association with HIV drug change and patient compliance

  2024cites this paper
• EFFECT OF INTRAMUSCULAR LIGNOCAINE INJECTION ON PROPOFOL HYPNOSIS IN DOGS

  2024cites this paper
• Advancements in Ocular Modelling and Simulations: Key Considerations and Case Studies

  2024cites this paper
• Characterization of two melanoma cell lines resistant to BRAF/MEK inhibitors (vemurafenib and cobimetinib)

  2024cites this paper
• Clinical pearls for the management of duloxetine patients with medical comorbidities

  2024cites this paper
• Insights into the Medical Evaluation of Ekbom Syndrome: An Overview

  2024cites this paper
• Pharmacomicrobiomics and Drug–Infection Interactions: The Impact of Commensal, Symbiotic and Pathogenic Microorganisms on a Host Response to Drug Therapy

  2023cites this paper
• Artemisia annua L. Extracts Irreversibly Inhibit the Activity of CYP2B6 and CYP3A4 Enzymes

  2023cites this paper
• Evaluation of the Potential Drug-Drug Interactions among Hospitalized Patients with COVID-19: A Cross-Sectional Study

  2023cites this paper
• A Graph-Based Approach to Mitigate Drug-Drug Interactions and Optimize Therapeutic Regimens

  2023cites this paper
• Classifying Polypharmacy According to Pharmacotherapeutic and Clinical Risks in Older Adults: A Latent Class Analysis in Quebec, Canada

  2023cites this paper
• Metabolic, renal, and hematological changes in chronic hepatitis C patients achieving rapid virologic response after 12 weeks of direct-acting antiviral treatment: A prospective cohort study

  2023cites this paper
• Drugs that induce and inhibit cytochrome P450. A study with real-world evidence

  2023cites this paper
• Clinical benefit of MAO-B and COMT inhibition in Parkinson’s disease: practical considerations

  2023cites this paper
• A retrospective cohort study of prescribing outcomes in outpatients treated with nirmatrelvir–Ritonavir for COVID-19 in an interdisciplinary community clinic

  2023cites this paper
• A critical appraisal of MAO-B inhibitors in the treatment of Parkinson’s disease

  2022cites this paper
• Drug-Disease Severity and Target-Disease Severity Interaction Networks in COVID-19 Patients

  2022cites this paper
• Rosemary and CoQ10 Alleviated the Detrimental Effects of Concomitant Administration of Acetaminophen and Carbamazepine by Accelerating Their Metabolism and Elimination

  2022cites this paper
• Frequency and characterization of potential drug interactions in dentistry—a cross-sectional study

  2022cites this paper
• A comparison of four drug–drug interaction databases for patients undergoing haematopoietic stem cell transplantation

  2022influential citation
• Potential Drug Interactions Between Psychotropics and Intravenous Chemotherapeutics Used by Patients With Cancer

  2022cites this paper
• Prevalence of Potential Pharmacological Interactions in Patients Undergoing Systemic Chemotherapy in a Tertiary Hospital

  2022cites this paper
• Cardio-Oncology Drug Interactions: A Scientific Statement From the American Heart Association

  2022cites this paper
• The Practice of the Community Pharmacists in Managing Potential Drug-Drug Interactions: A Simulated Patient Visits

  2022cites this paper
• Effect of probiotics on oxidative stress and inflammatory status in diabetic nephropathy: A systematic review and meta-analysis of clinical trials

  2021cites this paper
• Evaluation of drug-drug interactions in hospitalized patients on medications for OUD

  2021cites this paper
• Assessing Consistency of Drug-Drug Interaction-Related Information Across Various Drug Information Resources

  2021cites this paper
• Concrete Review on Cardiotoxicity Biomarkers

  2021cites this paper
• Interaction of alcohol with drugs of abuse and medicines

  2021cites this paper
• Implications of dopaminergic medication withdrawal in Parkinson’s disease

  2021cites this paper
• Potential Drug Interactions in Adults Living in Manaus: A Real-World Comparison of Two Databases, 2019.

  2021cites this paper
• Drug-Related Deaths in a Tertiary Hospital: Characteristics of Spontaneously Reported Cases and Comparison to Cases Detected from a Retrospective Study

  2021cites this paper
• Assessment of Awareness and Knowledge about Various Types of Drug-Related Interactions among Nurses in a Tertiary Care Hospital

  2021cites this paper
• Acute Pain Crisis Caused by Tramadol Remdesivir Drug–Drug Interaction

  2021cites this paper
• Potential Adverse Consequences of Combination Therapy with Gabapentin and Pregabalin

  2021cites this paper
• Pharmacological Interactions of Nintedanib and Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis in Times of COVID-19 Pandemic

  2021cites this paper
• Drug-Drug Interactions in Patients with COVID-19: A Retrospective Study at a Tertiary Care Hospital in Eastern India.

  2021cites this paper
• Influenza Vaccination for the Prevention of Cardiovascular Disease in the Americas: Consensus document of the Inter-American Society of Cardiology and the Word Heart Federation

  2021cites this paper
• Bradyarrhythmias in Cardio-Oncology

  2021cites this paper
• Drug interactions and adverse events in elderly heart disease patients

  2021cites this paper
• Effect of Vernonia Amygdalina Leaf on Cytochrome P450 2D6- and 3A4-Mediated Metabolism of Dextromethorphan in Healthy Nigerian Subjects

  2021cites this paper
• Evaluation of the drug–drug interaction potential for trazpiroben (TAK-906), a D2/D3 receptor antagonist for gastroparesis, towards cytochrome P450s and transporters

  2021cites this paper
• Cannabinoid Metabolites as Inhibitors of Major Hepatic CYP450 Enzymes, with Implications for Cannabis-Drug Interactions

  2021cites this paper
• Anti-hypertensive drugs deprescribing: an updated systematic review of clinical trials

  2021cites this paper
• Tannic acid enhances cisplatin effect on cell proliferation and apoptosis of human osteosarcoma cell line (U2OS)

  2021cites this paper
• Common anti-COVID-19 drugs and their anticipated interaction with anesthetic agents

  2021cites this paper
• Basic Pharmacokinetics

  2021cites this paper
• Evaluation of potential drug-drug interactions in intensive care unit.

  2021cites this paper
• Drug Interactions

  2021cites this paper
• Development and validation of a clinical instrument to predict risk of an adverse drug reactions in hospitalized patients

  2020cites this paper
• Knowledge, Attitude and Performance of Community Pharmacists towards Prescriptions in Mazandaran Province, Iran

  2020cites this paper
• A Comparative In Vitro Metabolic Study of Certain Pesticidal Phenyl N-Methyl-Carbamates

  2020cites this paper
• Potential Drug-Drug Interactions among Medications Prescribed to Adult Filipinos at a Primary Care Clinic in a Government Teaching Hospital

  2020cites this paper
• The Challenge of Potential Drug–Drug Interactions Among People Living With HIV on Antiretroviral Therapy: A Cross-Sectional Study in Selected Provinces in China

  2020cites this paper
• CYP1A2 and tobacco interaction: a major pharmacokinetic challenge during smoking cessation

  2020cites this paper
• Prevalence Of Potential Drug-Drug Interactions in Neonatal intensive Care Unit of A Tertiary Care Hospital: A Prospective Observational Study

  2020cites this paper
• Emergence of institutional antithrombotic protocols for coronavirus 2019

  2020cites this paper
• Prescription and administration errors of antimicrobials in a pediatric inpatient unit

  2020cites this paper
• Effectiveness and safety of sofosbuvir/velpatasvir ± ribavirin vs glecaprevir/pibrentasvir in genotype 3 hepatitis C virus infected patients.

  2020cites this paper
• Expression of cytochrome P450 isozyme transcripts and activities in human livers

  2020cites this paper
• Comparison of statistical methods for predicting penetration capacity of drugs into human breast milk using physicochemical, pharmacokinetic and chromatographic descriptors

  2020cites this paper
• Safety and Efficacy of Intermittent High-Dose Liposomal Amphotericin B Antifungal Prophylaxis in Haemato-Oncology: An Eight-Year Single-Centre Experience and Review of the Literature

  2020cites this paper
• IDENTIFIKASI POTENSI INTERAKSI OBAT PADA PASIEN DIABETES MELITUS TIPE 2 RAWAT INAP DI RUMAH SAKIT GUNUNG MARIA TOMOHON PERIODE JANUARI – MEI 2018

  2020cites this paper
• Clinically Relevant Interactions between Atypical Antipsychotics and Anti-Infective Agents

  2020cites this paper
• A PROSPECTIVE OBSERVATIONAL STUDY ON DRUG-DRUG INTERACTIONS IN CARDIAC PATIENTS AT A TERTIARY CARE HOSPITAL

  2020cites this paper
• Clinically relevant drug interactions between statins and antidepressants

  2020cites this paper
• Food–Drug Interactions with Fruit Juices

  2020cites this paper
• Clinically Relevant Drug Interactions in

  2020influential citation
• Discovery of Novel Indoleamine 2,3-Dioxygenase 1 (IDO1) and Histone Deacetylase 1 (HDAC1) Dual Inhibitors Derived from the Natural Product Saprorthoquinone

  2020cites this paper
• Peripheral Opioid Receptor Antagonists for Opioid-Induced Constipation: A Primer on Pharmacokinetic Variabilities with a Focus on Drug Interactions

  2020cites this paper
• Recommendations for the use of cannabinoids in the treatment of a cancer patient

  2019cites this paper
• Clinically relevant drug interactions between newer antidepressants and oral anticoagulants

  2019cites this paper
• Focus on the cetirizine use in clinical practice: a reappraisal 30 years later

  2019cites this paper
• Drug Interactions Prevalence: A Review

  2019cites this paper
• The influence of taurine and L-carnitine on 6 β-hydroxycortisol/cortisol ratio in human urine of healthy volunteers

  2019cites this paper
• Extrasynaptic δ‐GABAA receptors are high‐affinity muscimol receptors

  2019cites this paper
• Providing Alternative Measures for Addressing Adverse Drug-Drug Interactions

  2019cites this paper
• INTERAÇÃO MEDICAMENTOSA: UM AGRAVO A SAÚDE FRAGILIZADA

  2019cites this paper
• KITTEN following CAT on the long‐term use of rifampicin in hidradenitis suppurativa and effectiveness of oral contraceptives

  2019cites this paper
• Hepatitis C Update and Expanding the Role of Primary Care

  2019cites this paper